Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
2.
Pediatr Dermatol ; 35(2): 265-267, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29436008

RESUMEN

This retrospective study aimed to identify factors that predict treatment response in a cohort of Asian children with vitiligo. Shorter duration of vitiligo was associated with better repigmentation. Patients with focal vitiligo of short duration have a good chance of achieving repigmentation with topical agents alone.


Asunto(s)
Inhibidores de la Calcineurina/uso terapéutico , Glucocorticoides/uso terapéutico , Fototerapia/métodos , Prednisolona/uso terapéutico , Vitíligo/terapia , Administración Tópica , Pueblo Asiatico , Niño , Preescolar , Terapia Combinada , Femenino , Humanos , Masculino , Estudios Retrospectivos , Pigmentación de la Piel/efectos de los fármacos , Resultado del Tratamiento
3.
Australas J Dermatol ; 59(4): 322-327, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29635779

RESUMEN

BACKGROUND/OBJECTIVES: Controversy persists as to whether lichen planus pigmentosus and ashy dermatosis are separate clinical entities. This study was conducted to examine the clinicopathological features and treatment outcome of the two conditions. METHODS: A retrospective medical chart review of all patients who were diagnosed with lichen planus pigmentosus or ashy dermatosis was conducted. The information collected included the participants' age at onset, site of onset, duration of disease, presence of precipitating factors, distribution of disease, pigmentation and presence of symptoms. In patients from whom a biopsy was taken the histopathological reports were included. RESULTS: Altogether 26 patients with ashy dermatosis and 29 with lichen planus pigmentosus were included in the study. Compared with ashy dermatosis, lichen planus pigmentosus had a more localised distribution with a preponderance for facial involvement, compared with the truncal preponderance in ashy dermatosis. Ashy dermatosis tended to have a more stable clinical course than lichen planus pigmentosus, which was more likely to wax and wane. The utility of histopathology in differentiating between the two conditions is low. CONCLUSION: Ashy dermatosis and lichen planus pigmentosus, as defined in this study, appear to be two separate clinical entities with distinguishable clinical features and natural histories.


Asunto(s)
Hiperpigmentación/tratamiento farmacológico , Liquen Plano/tratamiento farmacológico , Adolescente , Adulto , Anciano , Niño , Progresión de la Enfermedad , Cara , Femenino , Humanos , Hiperpigmentación/etnología , Hiperpigmentación/patología , Liquen Plano/etnología , Liquen Plano/patología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Torso , Resultado del Tratamiento , Adulto Joven
4.
Australas J Dermatol ; 58(2): 130-134, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-26390992

RESUMEN

BACKGROUND: The clinical differentiation between pigmented basal cell carcinoma (BCC) and other benign pigmented skin lesions can be challenging even with an additional dermoscopic evaluation, especially if the lesion is small. In vivo reflectance confocal microscopy (RCM) is an emerging, non-invasive imaging tool that allows near-microscopic evaluation of skin lesions. The features of RCM for pigmented BCC and seborrhoeic keratosis have previously been described. However, the use of RCM to differentiate between these clinically and dermoscopically challenging pigmented skin lesions among Asians has not yet been demonstrated. OBJECTIVES: We aimed to evaluate the usefulness of non-invasive RCM to differentiate between clinically and dermoscopically challenging pigmented skin lesions among Asians in a series of 11 lesions. METHODS: Nine patients with 11 clinically and dermoscopically difficult to distinguish pigmented skin lesions were evaluated by RCM to differentiate between pigmented BCC and benign lesions. In all cases, a histological confirmation of the RCM diagnosis was obtained. RESULTS: The clinical or dermoscopical characteristics were non-specific in all 10 cases. RCM detected features of pigmented BCC in nine patients and seborrhoeic keratosis in one patient. These were all confirmed by histological examination. CONCLUSIONS: This case series shows the value of non-invasive in vivo RCM imaging in the differentiation of malignant and benign pigmented lesions. Early diagnosis of small, pigmented BCC allows earlier excision with better prognosis. Future biopsies of benign lesions in cosmetic areas could also be avoided.


Asunto(s)
Pueblo Asiatico , Carcinoma Basocelular/diagnóstico por imagen , Queratosis Seborreica/diagnóstico por imagen , Neoplasias Cutáneas/diagnóstico por imagen , Anciano , Anciano de 80 o más Años , Carcinoma Basocelular/patología , Diagnóstico Diferencial , Femenino , Humanos , Microscopía Intravital , Masculino , Microscopía Confocal/métodos , Persona de Mediana Edad , Neoplasias Cutáneas/patología
8.
Australas J Dermatol ; 55(2): 149-51, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24720427

RESUMEN

We reviewed the clinical characteristics and therapeutic response in cases of newly diagnosed bullous pemphigoid at the National Skin Centre between June 2009 and December 2010. Most (76%, n = 68/90) achieved clinical remission within 6 months of commencement of therapy. Oral mucosal involvement was identified as a risk factor associated with a prolonged duration of treatment beyond 6 months.


Asunto(s)
Antiinflamatorios/administración & dosificación , Penfigoide Ampolloso/tratamiento farmacológico , Prednisolona/administración & dosificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Niño , Quimioterapia Combinada , Femenino , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Mucosa Bucal , Penfigoide Ampolloso/diagnóstico , Inducción de Remisión , Estudios Retrospectivos , Complejo Vitamínico B/uso terapéutico , Adulto Joven
9.
Photodermatol Photoimmunol Photomed ; 29(3): 116-20, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23651271

RESUMEN

BACKGROUND: Photopatch testing is important for diagnosing photoallergic contact dermatitis. We aimed to evaluate the use of photopatch test at the National Skin Centre, Singapore. METHODS: All patients who had photopatch tests done between 2007 and 2011 at the National Skin Centre were included. RESULTS: Twenty-two patients were included. The mean age was 40.2. Female : male ratio was 3.4. The ethnic groups were Chinese (68%), Malay (4%), Indian (14%) and others (14%). Ten out of 22 patients (45.5%) had a positive photopatch test. There were 20 positive photopatch test reactions found in these 10 patients, and all 20 positive reactions were of current relevance. The frequencies of the positive photopatch test reactions were 2-hydroxy-4-methoxybenzophenone (oxybenzone) (n = 6), 2-hydroxymethoxymethylbenzophenone (mexenone) (n = 3), 2-ethylhexyl-4-dimethylaminobenzoate (n = 1), ketoprofen gel (n = 1) and the patient's own product (n = 9). CONCLUSIONS: Our study suggests that sunscreen is the most common photoallergen to date as opposed to musk ambrette, which was the most common photoallergen in our earlier study in 1991-1993. This finding is similar to the recent European Multicentre Photopatch Test Study.


Asunto(s)
Alérgenos/efectos adversos , Dermatitis Fotoalérgica/diagnóstico , Dinitrobencenos/efectos adversos , Mutágenos/efectos adversos , Protectores Solares/administración & dosificación , Adulto , Anciano , Alérgenos/administración & dosificación , Niño , Dermatitis Fotoalérgica/patología , Dermatitis Fotoalérgica/fisiopatología , Dinitrobencenos/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mutágenos/administración & dosificación , Singapur , Pruebas Cutáneas
10.
Photodermatol Photoimmunol Photomed ; 28(5): 269-71, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22971195

RESUMEN

Erythropoietic protoporphyria (EPP) is a rare autosomal dominant disorder of haem biosynthesis resulting from a partial decrease in ferrochelatase (FECH) activity which leads to the excessive accumulation of protoporphyrin in blood, erythrocytes and tissues. Cutaneous manifestations of photosensitivity usually appear in early infancy upon the first sun exposures. This normally requires the co-inheritance of a common hypomorphic FECH allele and a deleterious FECH mutation. Here, we report the first Singaporean Chinese patient with EPP characterized at the molecular level.


Asunto(s)
Alelos , Ferroquelatasa/genética , Hemo/genética , Trastornos por Fotosensibilidad/genética , Protoporfiria Eritropoyética/genética , Adulto , Pueblo Asiatico , Ferroquelatasa/metabolismo , Hemo/biosíntesis , Humanos , Masculino , Trastornos por Fotosensibilidad/sangre , Trastornos por Fotosensibilidad/etiología , Protoporfiria Eritropoyética/sangre , Protoporfiria Eritropoyética/complicaciones , Protoporfirinas/sangre , Singapur , Luz Solar/efectos adversos
12.
J Clin Aesthet Dermatol ; 11(3): 14-19, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29606995

RESUMEN

Introduction: Melasma is a common pigmentary disorder with a multifactorial etiology that can hinder its management. The aqueous extract of the fern Polypodium leucotomos (PLE), Fernblock® (IFC, Madrid, Spain), has demonstrated antioxidant and photoprotective activities and has been used for the treatment of several pigmentary disorders. The aim of this study was to evaluate the efficacy and safety of oral PLE in the treatment of melasma in Asian patients. Methods: Forty healthy adult patients with clinical diagnoses of melasma who were receiving treatment with topical 4% hydroquinone cream and sunscreen with a sun protection factor (SPF) of 50+ were recruited for inclusion in this study from the National Skin Centre in Singapore. They were randomized to receive either oral PLE supplementation or placebo for 12 weeks. Patients were assessed at baseline, Day 28, Day 56, and Day 84 using the modified Melasma Area and Severity Index (mMASI); melanin and erythema indexes; VISIA® photography (Canfield Scientific, Parsippany, New Jersey, USA); and the Melasma Quality of Life (MelasQoL) questionnaire. Adverse events were recorded. Results: Following four, eight, and 12 weeks of treatment, there were statistically significant differences between the mMASI scores of both groups as compared with the baseline scores (p≤0.01). mMASI scores of the PLE group at eight and 12 weeks were also significantly lower than those of the placebo group (p≤0.05). At the end of the study, a significant improvement was reached in both groups (both p≤0.01), with no significant differences between them. The scores of the melanin and erythema indices displayed a slight improvement in both groups, without significant differences among them. MelasQoL score showed an improvement in the PLE group versus the placebo group. Our results demonstrate that the PLE aqueous extract product significantly improves and accelerates the outcome reached with hydroquinone and sunscreen almost from the first month of treatment in comparison with the placebo. There were no significant side effects reported. Conclusions: The oral PLE aqueous extract product appears to be a safe and effective adjunctive treatment for melasma in combination with topical hydroquinone and sunscreen.

14.
Artículo en Inglés | MEDLINE | ID: mdl-28656913

RESUMEN

BACKGROUND: Late-onset vitiligo, defined as being aged 50 years and above at the point of clinical onset, remains poorly characterized till now. AIM: This study aims to describe the clinical characteristics and treatment response of patients with late-onset vitiligo. METHODS: We retrospectively reviewed the case records of all patients diagnosed with late-onset vitiligo, from January 1, 2010 to December 31, 2014. Information obtained included patient demographics, characteristics of vitiligo and treatment responses. RESULTS: Of the 3128 patients diagnosed with vitiligo over the 5-year period, 461 (14.7%) had late-onset disease. The study had more females (n = 260, 56.4%) than males, with an average onset age of 59.4 ± 7.4 years. Majority of patients were Chinese (n = 308, 66.8%) and 45 (9.8%) patients had an associated autoimmune disease. Focal vitiligo, defined as the localized presence of depigmented patches, was most common (n = 209, 45.3%). Treatment response was evaluated in 359 patients, of which 216 received monotherapy (topical creams: n = 210, 97.2%; phototherapy: n = 6, 2.8%) and 143 received both modalities. Fifty six (15.6%) patients received oral steroids. Patients who were treated with both topical creams and phototherapy yielded better clinical responses compared to those on monotherapy (P < 0.001) with 56.6% (n = 81) of them achieving good epidermal repigmentation, defined as >50% return of pigmentation compared to baseline (vs. n = 66, 30.6% in the monotherapy group). The choice of phototherapy (targeted, narrowband ultraviolet B or psoralen + ultraviolet A) did not significantly affect clinical response (P = 0.774). LIMITATIONS: This study is limited by its retrospective nature, the nonstandardized documentation resulting in the inability to determine disease progression and associated metabolic comorbidities and also by the gradual loss to follow-up of patients. CONCLUSION: Late-onset vitiligo is not uncommon and tends to be of the focal vitiligo subtype. Nonsegmented vitiligo is more prevalent than segmental vitiligo. Combination therapy with topical medications and phototherapy is superior to monotherapy.


Asunto(s)
Vitíligo/diagnóstico , Vitíligo/terapia , Edad de Inicio , Anciano , Anciano de 80 o más Años , Terapia Combinada/métodos , Fármacos Dermatológicos/administración & dosificación , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Fototerapia/métodos , Estudios Retrospectivos , Esteroides/administración & dosificación , Resultado del Tratamiento , Terapia Ultravioleta/métodos
15.
Photoacoustics ; 7: 20-26, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28652976

RESUMEN

Currently, imaging technologies that enable dermsurgeons to visualize non-melanoma skin cancers (NMSC) in vivo preoperatively are lacking, resulting in excessive or incomplete removal. Multispectral optoacoustic tomography (MSOT) is a volumetric imaging tool to differentiate tissue chromophores and exogenous contrast agents, based on differences in their spectral signatures and used for high-resolution imaging of functional and molecular contrast at centimeter scale depth. We performed MSOT imaging with two- and three-dimensional handheld scanners on 21 Asian patients with NMSC. The tumors and their oxygenation parameters could be distinguished from normal skin endogenously. The lesion dimensions and depths were extracted from the spectral melanin component with three-dimensional spatial resolution up to 80 µm. The intraclass correlation coefficient correlating tumor dimension measurements between MSOT and ex vivo histology of excised tumors, showed good correlation. Real-time 3D imaging was found to provide information on lesion morphology and its underlying neovasculature, indicators of the tumor's aggressiveness.

16.
Indian J Dermatol Venereol Leprol ; 82(6): 673-676, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27212282

RESUMEN

BACKGROUND: Progressive macular hypomelanosis is an acquired disorder characterized by hypopigmented macules mostly on the trunk and upper extremities. Although many treatment modalities have been proposed for this condition with variable success rates, there are few reports comparing their efficacy and relapse rates. AIM: To compare the efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis. METHODS: Case records of patients diagnosed with progressive macular hypomelanosis and treated in National Skin Centre for a six year period between 2008 and 2014 were reviewed. Patient demographics, distribution of hypopigmented macules, treatment efficacy and relapse rates were noted. RESULTS: A total of 108 patients were seen for progressive macular hypomelanosis over the study period; of these, 40 opted for no treatment but were followed up. Thirty-six were treated with topical antimicrobials and 32 with phototherapy. Of those untreated, 23% recovered spontaneously while 38% in the antimicrobial group and 90% in the phototherapy had remission of their hypopigmentation. After 2 years of follow-up, relapse occurred only in the phototherapy group. LIMITATIONS: The main limitation is the retrospective design whereby diagnosis is dependent on the attending dermatologist. CONCLUSIONS: Narrow-band ultraviolet B therapy appears to be the most effective treatment for progressive macular hypomelanosis but also has the highest potential for relapse. Response rates for antimicrobial therapy are lower and slower, but patients who responded did not relapse. A combination of topical/systemic antimicrobials with narrow-band ultraviolet B therapy might be the best option to hasten recovery and minimize relapse.


Asunto(s)
Antiinfecciosos/administración & dosificación , Progresión de la Enfermedad , Hipopigmentación/diagnóstico , Hipopigmentación/terapia , Mácula Lútea/patología , Fototerapia/tendencias , Administración Tópica , Adolescente , Adulto , Femenino , Estudios de Seguimiento , Humanos , Mácula Lútea/efectos de los fármacos , Masculino , Recurrencia , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
17.
J Cutan Aesthet Surg ; 8(3): 153-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26644739

RESUMEN

BACKGROUND AND OBJECTIVES: Post-acne scarring is a common and well-known sequelae of acne vulgaris. We aim to study the impact of post-acne scarring on the quality of life (QOL) among young adults in Singapore. SETTINGS AND DESIGN: This was a non-interventional prospective study. MATERIALS AND METHODS: Patients aged 21-40 years with atrophic and hypertrophic acne scars who attended the National Skin Centre, Singapore were recruited in the study. They answered a simple questionnaire and the clinical severity of their acne scars were assessed by the doctor. STATISTICAL ANALYSIS USED: Descriptive analyses using absolute and percentage frequencies were performed on all data. The test of significance was two-sided and was set at 5% (P ≤ 0.05). Differential analyses were conducted using the parametric, independent two-sample t-test and non-parametric Mann-Whitney U-test. The statistical assessments were performed using SPSS version 18.0. RESULTS: A total of 100 patients were studied. The mean patients' subjective self-scoring on the severity of their post-acne scars was 5.78/10 and the mean Dermatology Life Quality Index (DLQI) for post-acne scars was 5.61. Many (36%, n = 36) were self-conscious of their acne scars and 24%, (n = 24) felt that their acne scars was affecting their social activities. CONCLUSIONS: Our study showed that post-acne scars have a significant negative effect on the QOL of young adults. It highlights the need to increase public awareness of acne vulgaris and its sequelae through education programs and advocating early treatment to reduce the risk of scarring.

18.
Singapore Med J ; 55(1): e4-6, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24452984

RESUMEN

We report a case of atypical pityriasis rosea in a 24-year-old Malay man. He presented with an 11-month history of three recurrent and persistent episodes of pityriasis rosea associated with oral ulcers. The first episode lasted for one month and recurred within 14 days. The second episode lasted for three months and recurred within nine days. The third episode lasted for seven months. Although all three episodes were not preceded by any prodromal symptoms, a herald patch was noted on three different sites (the left iliac fossa, abdomen and chest) on each successive episode. Recurrent pityriasis rosea and its association with oral ulcers, although quite uncommon, have been reported in the literature. However, reports of multiple recurrences, with prolonged duration of each episode and very short remissions in between, have not been made. To the best of our knowledge, this is the first report of such unique presentation.


Asunto(s)
Pitiriasis Rosada/diagnóstico , Pitiriasis Rosada/patología , Adulto , Diagnóstico Diferencial , Exantema/diagnóstico , Exantema/patología , Humanos , Masculino , Úlceras Bucales/complicaciones , Úlceras Bucales/diagnóstico , Recurrencia , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA